- Home
- Publications
- Publication Search
- Publication Details
Title
Detecting At-Risk Alzheimer’s Disease Cases
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 60, Issue 1, Pages 97-105
Publisher
IOS Press
Online
2017-08-18
DOI
10.3233/jad-170231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- State of Play in Alzheimer’s Disease Genetics
- (2017) Jin-Bao Zhu et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer’s Disease
- (2017) Ina S. Almdahl et al. Frontiers in Aging Neuroscience
- Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease
- (2016) Claudio Villegas-Llerena et al. CURRENT OPINION IN NEUROBIOLOGY
- High Prevalence of Stress and Low Prevalence of Alzheimer Disease CSF Biomarkers in a Clinical Sample with Subjective Cognitive Impairment
- (2016) Marie Eckerström et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
- (2015) Celeste M. Karch et al. BIOLOGICAL PSYCHIATRY
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
- (2014) Frank Jessen et al. Alzheimers & Dementia
- The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
- (2014) Reisa Sperling et al. NEURON
- Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease
- (2014) Adam C. Naj et al. JAMA Neurology
- Cerebrospinal fluid biomarkers of Alzheimers disease in cognitively healthy elderly
- (2013) Lidia Glodzik Frontiers in Bioscience-Landmark
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- CERAD-neuropsychological battery in screening mild Alzheimer’s disease
- (2011) M. Sotaniemi et al. ACTA NEUROLOGICA SCANDINAVICA
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Subjective memory impairment in older adults: aetiology, salience and help seeking
- (2011) Aysha Begum et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Pre-dementia Memory Impairment is Associated with White Matter Tract Affection
- (2010) Ramune Grambaite et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
- (2010) Christopher C. Rowe et al. NEUROBIOLOGY OF AGING
- APOEpredicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging
- (2009) John C. Morris et al. ANNALS OF NEUROLOGY
- Diagnostic validity and added value of the geriatric depression scale for depression in primary care: A meta-analysis of GDS30 and GDS15
- (2009) Alex J. Mitchell et al. JOURNAL OF AFFECTIVE DISORDERS
- Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): The first twenty years
- (2008) Gerda G. Fillenbaum et al. Alzheimers & Dementia
- APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway
- (2008) Sigrid B Sando et al. BMC Neurology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started